MSA
IMGN

Marino Stram & Associates’s Immunogen Inc IMGN Stock Holding History

Marino Stram & Associates’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-100
Closed -$1K – 498
2017
Q4 		$1K Buy
+100
New +$617 ﹤0.01% 452

Other funds holding IMGN

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Marino Stram & Associates's IMGN Position: Q1 2018 in Review

Marino Stram & Associates sold out of Immunogen Inc (IMGN) in Q1 2018, closing a stake of 100 shares — an estimated $1K sold.

Marino Stram & Associates first reported a position in IMGN in Q4 2017 and held it in 1 quarter. The position peaked at $1K in Q4 2017. 204 funds tracked by Wall St. Rank hold IMGN as of Q1 2018.

  • Marino Stram & Associates reported no remaining Immunogen Inc position as of Q1 2018 after selling out during the quarter.
  • Marino Stram & Associates sold 100 Immunogen Inc shares in Q1 2018, an estimated $1K.
  • Marino Stram & Associates first reported a position in Immunogen Inc in Q4 2017 and held it in 1 quarter.
  • Marino Stram & Associates's Immunogen Inc position peaked at $1K in Q4 2017.
  • 204 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2018.

Based on Marino Stram & Associates's 13F filing for Q1 2018, filed 15 May 2018.